Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression

Sriyani Padmalatha,Yi-Tseng Tsai,Han-Chang Ku,Yi-Lin Wu,Tsung Yu,Su-Ying Fang,Nai-Ying Ko

DOI: https://doi.org/10.1016/j.clbc.2021.01.003

IF: 3.078

2021-10-01

Clinical Breast Cancer

Abstract:<p>This systematic review with a meta-regression was conducted to determine the risk of depression after mastectomy compared with breast reconstruction among women with breast cancer one year after surgery.</p><p>A literature search was conducted using four databases: Medline (Ovid), Embase, Cinahl, and the Cochrane Library for the period January 2000 to March 2019 according to PRISMA. Studies that measured the status of depression within one year and immediately after surgery were included. Outcomes related to depression were analyzed by using a pool of event rates and a risk ratio of 95% CI, <em>p</em>-value, and a fitting model based on the results of a heterogeneity test of mastectomy and BR. The statistical analysis was conducted using Comprehensive Meta-Analysis Software Version 3.0.</p><p>Nine studies met the inclusion criteria. 865 of these cases underwent mastectomy only, with a 22.2% risk of depression (95% CI 12.4 - 36.2). In 869 women who underwent BR, the risk of depression was 15.7% (95% CI 8.8 - 26.2). The depression risk ratio for mastectomy compared with BR was 1.36 (95 % CI 1.11 - 1.65). Cases with delayed reconstruction exhibited lower levels of depression (risk ratio 0.96, 95% CI 0.57- 1.01). The Beck Depression Inventory (BDI) scale showed high sensitivity, and the Hospital Anxiety Depression Scale with a cutoff point &gt;7 could measure even low to moderate depressive symptoms.</p><p>One in four women with breast cancer had symptoms of depression after mastectomy, both surgeries were associated with depression in women one year after surgery. This study will enable the development of proactive treatment plans before and after surgery to mitigate risk and prevent depression through the use of sensitive depression scales like BDI.</p>

oncology